Changes
/* Organisation Structure */
OLYMPUS CORPORATION, a Japan-based manufacturer, mainly manufactures and sells medical products, life and industrial products, imaging products, information communication products and other products. The Company operates in five business segments.
* The '''Medical segment is engaged in the manufacture Systems:''' Manufacture and sale of medical endoscopes, surgical endoscopes, endoscope disposal equipment and ultrasonic endoscopes. * The '''Life and Industrial segment provides :''' Provides biological microscopes, industrial microscopes, endoscopes for industrial use and non-destructive testing equipment. * The '''Imaging segment is engaged in the manufacture :''' Manufacture and sale of digital cameras and voice recorders. * The '''Information Communication segment is engaged in the sale :''' Sale of mobile terminals, such as cellular phones. * The '''Others segment is engaged in the development :''' Development of biomaterials and systems, industrial endoscopes, nondestructive inspection equipment, printers, mobile solutions and mobile contents services, the development and sale of package software, the sale of semiconductor-related equipment and electronic machines, as well as the development of systems.
<br>
===Key Facts===
{|border="2" cellspacing="0" cellpadding="4" width="54%" align="center"
|bgcolor = "#DBE5F195B3D7"|'''TypeEstablished'''|Public Company1919
|-
|bgcolor = "#DBE5F195B3D7"|'''Company SizeHeadquarters'''|34Tokyo,391 employeesJapan
|-
|bgcolor = "#DBE5F195B3D7"|'''Type'''|Public Company|-|bgcolor = "#95B3D7"|'''Website'''
|[http://www.olympus-global.com/en/ www.olympus-global.com]
|-
|bgcolor = "#DBE5F195B3D7"|'''FoundedRegional involvement'''|1919Worldwide
|-
|bgcolor = "#DBE5F195B3D7"|'''HeadquartersBusiness lines'''|Tokyo, JapanManufacture and Sales of precision machinery and instruments
|-
|bgcolor = "#DBE5F195B3D7"|'''Regional involvementEmployees'''|Worldwide34,391<br> Medical System Business: 15,000 Approx.
|-
|bgcolor = "#DBE5F195B3D7"|'''EmployeesGroup Companies'''|34,391Approx. 180 Subsidiaries
|-
|bgcolor = "#DBE5F195B3D7"|'''Chairman & CEO'''
|Tsuyoshi Kikukawa
|-
| bgcolor = "#DBE5F195B3D7"|'''President & COO'''
|Michael C. Woodford
|-
|bgcolor = "#95B3D7"|'''Consolidated Net Sales (2011)'''
|847.1 Billion YEN
|}
<br>
===Key Financials===
|-
|align = "center" rowspan = "2"|'''Revenue'''
|2011: ¥847¥ 847.10B 10 B / $10.58B58 B
|-
|2010: ¥ 883.08B 08 B / $11.03B03 B
|-
|align = "center" bgcolor = "#DBE5F1"|Revenue Change
|-
|align = "center" rowspan = "2"|'''Operating Income'''
|2011: ¥35¥ 35.4 B / $442M442 M
|-
|2010: ¥60¥ 60.1B 1 B / $751M751 M
|-
|align = "center" bgcolor = "#DBE5F1"|Operating Income Change
|-
|align = "center" rowspan = "2"|'''Net Profit'''
|2011: ¥7¥ 7.38B 38 B / $92.25M25 M
|-
|2010: ¥47¥ 47.76B 76 B / $597M597 M
|-
|align = "center" bgcolor = "#DBE5F1"|Net Profit Change
|-
|align = "center" rowspan = "2"|'''R&D Expenses'''
|2011: ¥67¥ 67.28B 28 B / $841M841 M
|-
|2010: ¥61¥ 61.85B 85 B / $773M773 M
|-
|}
<br>
Source: SEC fillings
===Patents Held by Business group===
{|border="2" cellspacing="0" cellpadding="4" width="100%"
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''Business Segment'''</font>
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''Medical Systems'''</font>
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''Life science & Industrial Systems'''</font>
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''Imaging Systems'''</font>
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''R&D/Innovation'''</font>
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''Total'''</font>
|-
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''Japan patents'''</font>
|align = " center" bgcolor = "#DBE5F1"|2941
|align = " center" bgcolor = "#DBE5F1"|1067
|align = " center" bgcolor = "#DBE5F1"|2021
|align = " center" bgcolor = "#DBE5F1"|1131
|align = " center" bgcolor = "#DBE5F1"|'''7160'''
|-
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''US patents'''</font>
|align = " center" bgcolor = "#DBE5F1"|1059
|align = " center" bgcolor = "#DBE5F1"|680
|align = " center" bgcolor = "#DBE5F1"|1534
|align = " center" bgcolor = "#DBE5F1"|974
|align = " center" bgcolor = "#DBE5F1"|'''4247'''
|-
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''China patents'''</font>
|align = " center" bgcolor = "#DBE5F1"|405
|align = " center" bgcolor = "#DBE5F1"|86
|align = " center" bgcolor = "#DBE5F1"|444
|align = " center" bgcolor = "#DBE5F1"|90
|align = " center" bgcolor = "#DBE5F1"|'''1025'''
|-
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''Other patents'''</font>
|align = " center" bgcolor = "#DBE5F1"|948
|align = " center" bgcolor = "#DBE5F1"|249
|align = " center" bgcolor = "#DBE5F1"|102
|align = " center" bgcolor = "#DBE5F1"|165
|align = " center" bgcolor = "#DBE5F1"|'''1464'''
|-
|bgcolor = "#4F81BD"|<font color="#FFFFFF">'''Total'''</font>
|align = " center" bgcolor = "#DBE5F1"|'''5353'''
|align = " center" bgcolor = "#DBE5F1"|'''2082'''
|align = " center" bgcolor = "#DBE5F1"|'''4101'''
|align = " center" bgcolor = "#DBE5F1"|'''2360'''
|align = " center" bgcolor = "#DBE5F1"|'''13896'''
|-
|}
<br>
In Medical systems business, the company owns 39% of the total number of patents held by the company, with Japanese patents being the highest contributor to that.
==Business Overview==
===Organisation Structure===
[[Image:OrgChart_Oympus.png|centre]]
<br>
In April 2011, the company launched their regional headquarters for Asia and Oceania to coordinate regional strategy and facilitate business infrastructure development.<br>
Source: Company website, Linkedin
==Medical Systems Business==
Medical systems business has the following business lines:
* '''Endoscopes''' <br>Endoscopic video imaging systems, medical information systems, fiberscope systems, broncho endoscope systems, endoscopic ultrasound systems; ultrasound fiberscopes; ultrasound probes; ultrasound centers; ultrasound-guided needle puncture systems; cleaning, disinfecting and sterilization systems; medical treatment peripherals; ancillary products
* '''MIP''' includes surgical endoscopes and treatment equipments** '''Endosurgery''' <br>Endoscopy products for gastroenterological surgery, thoracic surgery, urology, gynecology, orthopedic surgery, neurosurgery, cardiovascular surgery, anesthesiology and otolaryngology; treatment and surgical equipment; peripherals** '''Endotherapy''' <br>Endotherapy products
===Revenue===
Medical systems business is the biggest business segment of Olympus corporation:* Net sales ratio : 40% approx.* Contribution to total corporate operating income :109% approx. :(before corporate allocation of expenses)<br>{|border="2" cellspacing="0" cellpadding="4" width="81%" align="center"|bgcolor = "#376091"|<gflashfont color="#FFFFFF">900 600 http:'''Metrics ( in Billion Yen)'''</font>|bgcolor = "#376091"|<font color="#FFFFFF">''' '''</dolcera.comfont>|align = "right" bgcolor = "#376091"|<font color="#FFFFFF">'''2009'''</uploadfont>|align = "right" bgcolor = "#376091"|<font color="#FFFFFF">'''2010'''</files/Medical_Device_Segment.swffont>|align = "right" bgcolor = "#376091"|<font color="#FFFFFF">'''2011'''</gflashfont>|-|align = "left" bgcolor = "#95B3D7" rowspan = "3"|'''Medical Systems'''|'''Domestic'''|align = "right"|76.2|align = "right"|75.1|align = "right"|79.4|-|'''Overseas'''|align = "right"|307.6|align = "right"|275.7|align = "right"|275.9|-|bgcolor = "#95B3D7"|'''Total'''|align = "right" bgcolor = "#95B3D7"|'''383.89'''|align = "right" bgcolor = "#95B3D7"|'''350.75'''|align = "right" bgcolor = "#95B3D7"|'''355.46'''|-|align = "center" bgcolor = "#DBE5F1" rowspan = "3"|Endoscopes|align = "center"|Domestic|align = "right"|44.6|align = "right"|40.9|align = "right"|43.8|-|align = "center"|Overseas|align = "right"|168.3|align = "right"|151|align = "right"|151.6|-|align = "center" bgcolor = "#DBE5F1"|'''Total'''|align = "right" bgcolor = "#DBE5F1"|'''212.9'''|align = "right" bgcolor = "#DBE5F1"|'''191.9'''|align = "right" bgcolor = "#DBE5F1"|'''195.5'''|-|align = "center" bgcolor = "#DBE5F1" rowspan = "3"|MIP|align = "center"|Domestic|align = "right"|31.6|align = "right"|34.2|align = "right"|35.6|-|align = "center"|Overseas|align = "right"|139.3|align = "right"|124.6|align = "right"|124.3|-|align = "center" bgcolor = "#DBE5F1"|'''Total'''|align = "right" bgcolor = "#DBE5F1"|'''170.9'''|align = "right" bgcolor = "#DBE5F1"|'''158.8'''|align = "right" bgcolor = "#DBE5F1"|'''159.9'''
|-
|}
<br>
===Projections for FY 2012===
<br>
* In endoscopes, new shipments of some products (Lucera) have ground to a halt, but the company expects to see a rebound in 2H2nd Half. For the year as a whole it projects endoscope sales will be down 5% YoY.* The company estimates 1H 1st Half sales in the medical systems division at JPY165bn (-6% YoY), and OP at JPY27bn; it projects 2H 2nd Half sales at JPY195bn (+8%) and OP at JPY43bn.
* In the medical systems division, new product launches are planned for both surgical endoscopes and energy devices (treatment tools).
* It projects sales of MIPs (surgical endoscopes, treatment equipment) at JPY180.5bn (+10% YoY). Sales in FY3/11 were flat YoY due mainly to the strength of the yen, but positive growth is expected this year.
* The company projects sales of gastrointestinal endoscopes at JPY164bn, -5% YoY, reflecting production setbacks in 1H1st Half.
* The earthquake’s impact has caused bottlenecks in purchasing of parts and materials for gastrointestinal endoscopes,leading to delays in product launches. In the latest telephone conference, the company offered no new information about timing. We believe there has been no real change from the company’s comments at the results briefing in May,and it remains to be seen whether the company will be able to launch its new products this fiscal year. The company’s FY3/12 earnings forecasts do not reflect any contribution from new products. Sales in the medical systems division got off to a slow start, falling short of projections in April-May.
<br>
===Geographic Presence===
[[Image:Geo_olympus.PNG|center|1000px|thumb| Source: [http://www.olympus-global.com/ Olympus]]]
<br>
===Corporate Strategic Plan===
* Expand the endoscopic business base ( Gastrointestinal )
** Gain a dominant market share and ensure profitability in the imaging field
*** Early introduction and diffusion of next generation endoscope systems
*** Establishment of a significant presence in emerging markets
*** Diagnostic technology to promote early detection
*** Endoscope technology to achieve definite diagnoses
** Imaging technology for achieving early detection :Narrow Band Imaging (NBI)
*** Acquisition of approval of insurance reimbursement for medical effects from early cancer detection using NBI ( in Japan)
*** Initiative for standardization of NBI observation as diagnosis
* Growth Drivers
** Expansion of EndoTherapy field
*** Introduce Visera Elite, a new integrated endoscopy video system
*** Secure a 30% share of the global operating room imaging market in 2015
*** Expand the lineup of differentiated products focused on minimally invasive surgical techniques
*** Achieve the top share (30%) of the existing global endoscopy market in 2015. Also, secure top share of the Japanese market and further strengthen the sales structure
** Expansion of Chinese and Asian market
*** Introduce popularly prices models
*** Expand the size of the market and share in such markets. Increase the number of endoscopists and improve their training.
==Endoscopes Business==
===Product Portfolio===
The company offers endoscopes in various specialties. The following is a comprehensive list of endoscopes ,according to specialty, that the company offers:<br>* [http://www.olympusamerica.com/msg_section/msg_endoscopy_ebus_bronchoscopes.asp EBUS Bronchoscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_fiber_bronchoscopes.asp Fiber Optic Bronchoscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_video_bronchoscopes.asp Video Bronchoscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_capsulescopes.asp Capsule Endoscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_choledochoscopes.asp Choledochoscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_colonoscopes.asp Colonoscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_duodenoscopes.asp Duodenoscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_echoendoscopes.asp Echoendoscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_enteroscopes.asp Enteroscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_esophagoscopes.asp Esophagoscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_gastroscopes.asp Gastroscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_laryngoscopes.asp Laryngoscopes]* [http://www.olympusamerica.com/msg_section/msg_maf.asp Intubation Scopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_rhinolaryngoscopes.asp Rhinolaryngoscopes]* [http://www.olympusamerica.com/msg_section/msg_endoscopy_sigmoidoscopes.asp Sigmoidoscopes]
[[Image:prodcuts_olympus.PNG|center|frame| [http://www.olympus-global.com/en/ Olympus]]]
<br>
<br>
==Gastrointestinal Endoscopes Business==
===Market Share===
[[Image:CoshareGIshare.PNG|center|frame|Source: Espicom]]
<br>
{|border="2" cellspacing="0" cellpadding="4" width="52%" align="center"
* PolyLoop Ligating Loop: Proprietary ligating loop for prophylactic hemostasis
* Biopsy Forceps: Specially designed to minimize damage to the enteroscope with it's stainless steel construction.
|-
|align = "center" rowspan = "1" bgcolor = "#4F81BD"|'''Sigmoidoscopy'''
|bgcolor = "#DBE5F1"|Endoscopic examination, therapy or surgery of the sigmoid flexure
|[[Image:Sig.PNG|100px]]
|
* PCF-S: Easy-reach L/R adapter (MAJ-1072) improves control and comfort for smaller hands and has a soft insertion tube for easier insertion and improved patient comfort. It is compatible with CV-180, CV-160 and CV-140 video processors.
* OSF-V60: 730mm working length gives access to the entire sigmoid colon. It has a Slim, 11.3mm insertion tube provides excellent handling while reducing patient discomfort.
* CF-Q160S: Superior image quality with large display size provides enhanced details throughout the image plane. When used in combination with the company's dedicated flushing pump and CV-160 video system center, a continuously clear view is ensured by a forward water jet that removes obstacles inside the colon at the touch of a switch on the scope.
* OSF-4: 700mm working length facilitates complete insertion. Generous 3.2mm instrument channel accommodates a wide variety of accessories.
|-
|}
===New Products===
*'''Scope Guide:'''<br>[[Image:Scope.PNG|right|140px]] is an exclusive Olympus technology designed to provide a real-time 3D image of the shape and configuration of the colonoscope inside the body. ScopeGuide assists with finding the optimal location to apply abdominal pressure, easier, more confident scope insertion, and early loop identification. The use of ScopeGuide during colonoscopies may lead to less patient discomfort.<br> By seeing the shape of the entire scope as it moves through the body, ScopeGuide provides additional visual information that is particularly helpful during difficult colonoscopies. The endoscopist can evaluate the extent of looping and get a better sense of which rotational maneuvers will be required to straighten out various loop formations that can occur during colonoscopy.
* '''Evis Lucera Colono-Videoscope:''' It helps in reducing the burden on patients and improving performance for both the inspection and treatment of colorectal cancer through the incorporation of two new functions, namely, high flexibility and highly responsive control at the insertion site, while adopting a thinner scope.
* '''Evis Lucera Gastrointestinal Videoscope:''' This slim gastrointestinal videoscope can be inserted through the nasal tract or the mouth to realise high quality images and is suited for the examination of lesions in the upper digestive tract, for example, in the stomach.
** 6 white LED lights always ensure a clear field of view
** Compact battery with energy efficient technology
:The company is developing technologies to expand the application of capsule endoscopes to the stomach and large bowel.<br>Source: Company website, SEC fillings
<br>
